Bellus Health

Investors & Media

Press Releases

Press Releases

10/22/20
BELLUS Health Closes US$40 Million Public Offering of Common Shares in Canada and the United States, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
LAVAL, Quebec --(BUSINESS WIRE)--Oct. 22, 2020-- BELLUS Health Inc. (NASDAQ: BLU)(TSX: BLU) (the “Company” or “BELLUS Health”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough and other hypersensitization-related disorders, today announced
Displaying 1 - 10 of 21